Kiniksa Pharmaceuticals International, plc Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Kiniksa Pharmaceuticals International, plc Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.66M, a 11.6% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$26.2M, a 36.4% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Operating Income (Loss) for 2023 was -$25.2M, a 358% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Operating Income (Loss) for 2022 was $9.77M.
  • Kiniksa Pharmaceuticals International, plc annual Operating Income (Loss) for 2021 was -$157M, a 0.46% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.2M -$35M -358% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $9.77M +$166M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$157M +$727K +0.46% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$157M +$12.6M +7.41% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$170M -$61.8M -57.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$108M -$42.8M -65.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$65.4M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.